A detailed history of Vident Advisory, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 4,415 shares of LNTH stock, worth $385,517. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,415
Previous 13,270 66.73%
Holding current value
$385,517
Previous $1.07 Billion 54.52%
% of portfolio
0.01%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$77.7 - $123.62 $688,033 - $1.09 Million
-8,855 Reduced 66.73%
4,415 $485 Million
Q2 2024

Aug 14, 2024

BUY
$58.87 - $83.05 $78,061 - $110,124
1,326 Added 11.1%
13,270 $1.07 Billion
Q1 2024

May 14, 2024

BUY
$51.07 - $68.26 $437,772 - $585,124
8,572 Added 254.21%
11,944 $743 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $187,483 - $262,645
3,372 New
3,372 $209 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.